Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

CLINDAMYCIN PHOSPHATE

CLINDAMYCIN PHOSPHATE

Standard Dose
EQ 1% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE is listed in Drugs@FDA under application 219612 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength SWAB;TOPICAL - EQ 1% BASE Sponsor CARNEGIE Submission history Latest submission status date: 2025-06-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE is listed in Drugs@FDA under application 219612 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength SWAB;TOPICAL - EQ 1% BASE Sponsor CARNEGIE Submission history Latest submission status date: 2025-06-13 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) | Drug Monograph | MedicHelpline